Incidence and risk factors for suicide and attempted suicide following a diagnosis of hematological malignancy.
Hultcrantz M et al. Cancer Med. 2014 Aug 26. doi: 10.1002/cam4.316. [Epub ahead of print].

Bortezomib in multiple myeloma: systematic review and clinical considerations.
Kouroukis TC et al. Curr Oncol. 2014 Aug;21(4):e573-603. doi: 10.3747/co.21.1798.

Novel Agents In Cns Myeloma Treatment.
Gozzetti A et al. Cent Nerv Syst Agents Med Chem. 2014 Aug 19. [Epub ahead of print].

Not too little, not too much-just right! (Better ways to give high dose melphalan).
Shaw PJ et al. Bone Marrow Transplant. 2014 Aug 18. doi: 10.1038/bmt.2014.186. [Epub ahead of print].

Clinical features and treatment outcome in newly diagnosed Chinese patients with multiple myeloma: results of a multicenter analysis.
Lu J et al. Blood Cancer J. 2014 Aug 15;4:e239. doi: 10.1038/bcj.2014.55.

Hematologic malignancies of the pancreas.
Sandrasegaran K et al. Abdom Imaging. 2014 Aug 15. [Epub ahead of print].

Evolution of treatment regimens in multiple myeloma: a social network analysis.
Mahony H et al. PLoS One. 2014 Aug 13;9(8):e104555. doi: 10.1371/journal.pone.0104555. eCollection 2014.

Mortality study of civilian employees exposed to contaminated drinking water at USMC Base Camp Lejeune: a retrospective cohort study.
Bove FJ et al. Environ Health. 2014 Aug 13;13(1):68. [Epub ahead of print].

The role of risk tools in diagnosing cancer in primary care.
Emery J et al. Aust Fam Physician. 2014 Aug;43(8):508-12.

Optimizing Dosing of Oncology Drugs.
Minasian L et al. Clin Pharmacol Ther. 2014 Aug 8. doi: 10.1038/clpt.2014.153. [Epub ahead of print].

The role of transplant in multiple myeloma.
Mei M et al. J Natl Compr Canc Netw. 2014 Aug;12(8):1131-8.

Long-term survival, prevalence, and cure of cancer: A population-based estimation for 818,902 Italian patients and 26 cancer types.
Dal Maso L et al. Ann Oncol. 2014 Aug 22. pii: mdu383. [Epub ahead of print].

Alcohol intake, alcoholic beverage type and multiple myeloma risk: a meta-analysis on 26 observational studies.
Psaltopoulou T et al. Leuk Lymphoma. 2014 Aug 22:1-30. [Epub ahead of print].

Controversies in Multiple Myeloma: to Transplant or Not?
Preeshagul IR et al. Curr Hematol Malig Rep. 2014 Aug 22. [Epub ahead of print].

The potential of miRNAs as biomarkers for multiple myeloma.
Rocci A et al. Expert Rev Mol Diagn. 2014 Aug 7:1-13. [Epub ahead of print].

The ecology of cancer from an evolutionary game theory perspective.
Pacheco JM et al. Interface Focus. 2014 Aug 6;4(4):20140019. doi: 10.1098/rsfs.2014.0019.

The Tao of myeloma.
Boise LH et al. Blood. 2014 Aug 5. pii: blood-2014-05-578732. [Epub ahead of print].

The health implications of low hemoglobin deferral in infrequent blood donors.
Annen K et al. Transfusion. 2014 Aug 1. doi: 10.1111/trf.12801. [Epub ahead of print].

Multiple Myeloma in the Older Adult: Better Prospects, More Challenges.
Wildes TM et al. J Clin Oncol. 2014 Jul 28. pii: JCO.2014.55.1028. [Epub ahead of print].

Light chain multiple myeloma, clinic features, responses to therapy and survival in a long-term study.
Zhang JJ et al. World J Surg Oncol. 2014 Jul 28;12(1):234. [Epub ahead of print]